Tags Posts tagged with "Dave and Sherri Seyfert"

Dave and Sherri Seyfert

by -
0 125
Many battling the autoimmune disease APS type 1 and their families, above, are shown attending a symposium at Stony Brook University in 2017 organized by Dave and Sherri Seyfert of Stony Brook. Photo from the Seyferts

By Leah Chiappino

After a house fire this summer, one Stony Brook family learned a valuable lesson.

“People come first, things a distant second,” Dave Seyfert said.

Firefighters respond to a fire at the Seyferts’ home in July. Photos from the Seyferts

He and his wife Sherri are two of the founders of the APS Type 1 Foundation, which aims to make physicians more aware of the rare disorder. APS type 1 is a rare autoimmune disease that affects one in two million people in the United States.

The couple arrived home one day to the house fire shortly after the foundation’s third symposium in National Harbor, Maryland, in July. The family is currently renting a house and is hoping to return to their own home in a few months.

The Seyferts said that their spirits were not diminished by the tragedy, in which everyone, including the family dog, was safe, because they are pleased with the research and outcome of the symposium. When discussing how well they were coping, Dave Seyfert said, “APS puts things in perspective. When you have a child that’s sick your whole world stops. Nothing else is important — it doesn’t matter what you look like or if you’ve slept.”

He added in a follow-up email, “Sherri and I also share a deep faith in God which again helps put things in perspective.”

As reported by TBR News Media in 2017, the Seyferts’ son, Matthew, was diagnosed with autoimmune polyglandular syndrome type 1, known as APS-1, in 2006. The condition causes vitamin D, which provides calcium to the bones and muscles, to have a difficult time metabolizing. While symptoms can include bone mass problems, cramping and an irregular heartbeat, all patients are plagued with Addison’s disease, hyperthyroidism and candidiasis.

According to Dave Seyfert, APS-1 is unique among other genetic disorders because there is only one gene mutation, so researchers think there is a link to discovering cures for other autoimmune diseases, such as diabetes.

The symposiums are meant to be a haven for APS-1 research, as well as a meetup for families and patients to build a community of support.

“There are a lot of families going through a rare diagnosis, and you feel like you are all by yourself,” Dave Seyfert said. “We want to share with other families that it’s amazing what we achieved [in terms of research] by working together.”

“We want to keep going until we find every APS patient.”

— Sherri Seyfert

The foundation, whose mission involves research, education and raising awareness, became a 501(c)(3) in 2014. That was eight years since the Seyferts had started hosting basket raffles. Also, Todd and Heather Talarico of New Jersey, the former being the current foundation president, organized their first golf outing in 2006 that raised approximately $35,000 for the National Organization for Rare Disorders, known as NORD, which was used to grant research. According to Sherri Seyfert the foundation recently funded its seventh research grant for $100,000 through NORD, which takes the organization’s grant funding to more than $500,000.

Two board members, Robin Finch and Jennifer Orange, both of whom have a child with APS-1, joined in 2016, after the foundation held its first symposium, which was located in Toronto in 2015.

“Researchers from all over the world came and spoke on APS type 1,” Sherri Seyfert said. “It was the first time this community of patients and families were able to come together and met each other.”

A second symposium in 2017 was hosted personally by the Seyferts at Stony Brook University.

The board has grown to its current six members and, in addition, they have quarterly conference calls with physicians from all over the world so they can collaborate.

Dave Seyfert said he is pleased with the outreach of the foundation. He said Todd Talarico was on the TV show “Mystery Diagnosis,” and a grandmother watching realized her granddaughter suffered from the disease. An American serviceman stationed in Italy was in the hospital with his son and, upon doing research, came across the foundation’s website and realized his son had APS-1. Patients at Stony Brook Children’s Hospital were diagnosed upon a doctor reading a research article on APS-1 written by physicians all over the world, who connected at past symposiums and were published in The New England Journal of Medicine. The article was funded by the foundation.

Furthermore, NORD has granted the foundation funding for a comprehensive study of APS-1, logging patients and their symptoms. While 95 percent of the condition is treatable, experts estimate that a thousand patients are living

“We want to keep going until we find every APS patient,” Sherri Seyfert said. “People pass away from not knowing, and so many struggle with so many health issues and organ damages for years because they are not diagnosed quickly enough.”

Finch, a California-based attorney who was assisted by Todd Talarico in getting her daughter diagnosed, is the foundation’s recording secretary and feels as though she owes a lot to the Seyferts.

“The passion and the time and energy they gave to the symposium at Stony Brook was just invaluable,” Finch said. “They’re both just the kind people who try so much to make Matthew and other kids’ lives better. Dave, in particular, feels so deeply about things, and his commitment to my family and the disease’s community is so incredible. They’re the heart and soul of this group.”

Orange, the foundation’s vice president, added praise for the Seyferts.

“The Seyferts are community builders and have a great way of bringing people together and getting people to realize what a community can do,” she said.

Local family goes from organizing basket raffles to hosting international symposium

Many battling the autoimmune disease APS Type 1 and their families, above, attended a symposium at Stony Brook University organized by Dave and Sherri Seyfert of Stony Brook. Photo from Sherri Seyfert

By Rita J. Egan

When their son Matthew, now 17, was diagnosed with Autoimmune Polyglandular Syndrome Type 1 11 years ago, Sherri and Dave Seyfert’s world was turned upside down.

The diagnosis led the Stony Brook couple to join the cause to find a cure for the rare autoimmune disease that affects 1 in 2 million people in the United States, and the results of their efforts culminated recently with the Second International Symposium on APS Type 1 at Stony Brook University July 13 through 15, an event they organized and hosted.

“Each time we have a hospitalization or emergency room visit or are in ICU, for the most part we learn something that will keep us out of there for that particular thing next time.”

—Dave Seyfert

The Seyferts with Todd and Heather Talarico of New Jersey founded the APS Type 1 Foundation with the main goal of making physicians more aware of the rare disorder. In the last decade, the families have raised $500,000 for research through fundraising events, which includes basket raffles organized by the Seyferts at the Setauket firehouse on Main Street.

The Seyferts said the basket raffles were always popular thanks to the support of local businesses and residents, and their fundraising success led to the hosting of the July symposium that gave researchers an opportunity to share information. It also provided patients and their loved ones a chance to find a much-needed support system.

Attendees traveled from all over the country as well as Ireland and South America to share their experiences. The couple said life after a diagnosis can sometimes be lonely for families.

“The symposium gave [families] the opportunity to share, to be able to provide each other with support and also listen to the researchers giving them hope that there’s a lot of research going on out there,” Sherri Seyfert said.

The Seyferts said “there are a lot of moving pieces” when it comes to APS Type 1, because the body has trouble metabolizing Vitamin D, which helps in the process of providing calcium to bones and muscles, including the heart.. A patient can experience various symptoms including cramping, bone mass problems and an irregular heart rhythm. However, a triad of disorders identifies the disease: adrenal insufficiency (Addison’s), hypoparathyroidism, and Candidiasis.

The Seyfert’s son Matthew was diagnosed when he was six years old. Photo from Sherri Seyfert

“So everybody is actually a little bit different as far as what conditions they have, even though they’ll share three things,” Dave Seyfert said. 

He said the disease overall is manageable, even though patients can develop something new every decade of their life.

“Each time we have a hospitalization or emergency room visit or are in ICU, for the most part we learn something that will keep us out of there for that particular thing next time,” the father said.

He said the couple chose the university to recognize the contributions of Stony Brook Children’s Hospital  to the community and their quick diagnosis of Matthew when he was six years old. At the time he was experiencing excessive fatigue and suffered a seizure in kindergarten. His father said it took 48 hours for the team at Stony Brook to diagnosis his son. It can sometimes take years to identify the disease in a patient.

The couple said the symposium included a section for children and teenagers to interact separately from adults. Matthew attended the event and assisted in escorting guests and served as a microphone runner during the Q&A.

Dr. Andrew Lane,  professor of clinical pediatrics in the Division of Pediatric Endocrinology at Stony Brook Medicine, and Dr. Mark Anderson, director of University of California, San Francisco’s Medical Scientist Training Program, were among the speakers at the symposium.

“I think that [the Seyferts] are just a fantastic example of encouraging people to believe that for whatever medical condition or other condition in the world they are interested in fixing, even small things can make a difference.”

—Dr. Andrew Lane

“I thought it was really uplifting,” Lane said. “It was really great to see all the families supporting each other. It was also great for the physicians and scientists in the audience to interact, and informally and formally hear each other’s work and help recognize what areas need further work.”

Anderson, who met the Seyferts at the first symposium in Toronto, Canada in 2015, said there is hope for those diagnosed with APS Type 1. He said with stem cell transplants, the thymus, a gland that sits in front of the heart and plays a part in APS Type 1, may possibly be reprogrammed.

“That’s the type of thing that families want to know that someone is working on the problem,” Anderson said.

Lane, who was part of the team that diagnosed Matthew, said the symposium was the perfect opportunity for families to raise concerns directly to internationally recognized researchers in the field, and he is amazed that the family went from organizing basket raffles to hosting a symposium.

“I think that [the Seyferts] are just a fantastic example of encouraging people to believe that for whatever medical condition or other condition in the world they are interested in fixing, even small things can make a difference and sometimes turn into really big things,” Lane said.

Matthew was too shy to comment on the event, according to his mother, but she said the whole family was left with hope after the three-day symposium.

“People were thanking me, and my response always was it’s an honor to be able do this for everyone,” his mother said.

For more information about APS Type 1 and future events, visit www.apstype1.org.